These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 24290142)

  • 61. Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.
    Kim SJ; Pak K; Chang S
    Br J Radiol; 2016; 89(1058):20150673. PubMed ID: 26607643
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative characteristics of quantitative indexes for 18F-FDG uptake and metabolic volume in sequentially obtained PET/MRI and PET/CT.
    Lee SJ; Paeng JC; Goo JM; Lee JM; Cheon GJ; Lee DS; Chung JK; Kang KW
    Nucl Med Commun; 2017 Apr; 38(4):333-339. PubMed ID: 28252525
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 18F-FDG-PET/CT in fever of unknown origin: clinical value.
    Buch-Olsen KM; Andersen RV; Hess S; Braad PE; Schifter S
    Nucl Med Commun; 2014 Sep; 35(9):955-60. PubMed ID: 24801131
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Invasive cribriform carcinoma of the breast: mammographic, sonographic, MRI, and 18 F-FDG PET-CT features.
    Lee YJ; Choi BB; Suh KS
    Acta Radiol; 2015 Jun; 56(6):644-51. PubMed ID: 24938660
    [TBL] [Abstract][Full Text] [Related]  

  • 66. (18)F-FDG-PET/CT findings in pancreatic metastasis.
    Hu S; Zhang J; Zuo C; Cheng C; Liu Q; Sun G
    Radiol Med; 2015 Oct; 120(10):887-98. PubMed ID: 25795439
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
    Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
    Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.
    Wu HB; Wang L; Wang QS; Han YJ; Li HS; Zhou WL; Tian Y
    Biomed Res Int; 2015; 2015():243681. PubMed ID: 25879020
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic Value of FDG-PET/CT Total Lesion Glycolysis for Patients with Resectable Distal Bile Duct Adenocarcinoma.
    Lee EJ; Chang SH; Lee TY; Yoon SY; Cheon YK; Shim CS; So Y; Chung HW
    Anticancer Res; 2015 Dec; 35(12):6985-91. PubMed ID: 26637926
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.
    Hu SL; Yang ZY; Zhou ZR; Yu XJ; Ping B; Zhang YJ
    Nucl Med Commun; 2013 Jun; 34(6):533-9. PubMed ID: 23503000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ¹⁸F-FDG PET/CT and contrast enhanced CT in differential diagnosis between leiomyoma and gastrointestinal stromal tumor.
    Hirose Y; Kaida H; Kawahara A; Kurata S; Ishibashi M; Abe T
    Hell J Nucl Med; 2015; 18(3):257-60. PubMed ID: 26574696
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
    Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FDG PET/CT in the management of colorectal and anal cancers.
    Agarwal A; Marcus C; Xiao J; Nene P; Kachnic LA; Subramaniam RM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1109-19. PubMed ID: 25341152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT.
    Goudarzi B; Jacene HA; Wahl RL
    J Nucl Med; 2008 Oct; 49(10):1585-92. PubMed ID: 18794276
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Value of ¹⁸F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension.
    Ma Q; Xin J; Zhao Z; Guo Q; Yu S; Xu W; Liu C; Zhai W
    Eur J Radiol; 2013 Jun; 82(6):e302-6. PubMed ID: 23434453
    [TBL] [Abstract][Full Text] [Related]  

  • 76. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
    Sperti C; Pasquali C; Decet G; Chierichetti F; Liessi G; Pedrazzoli S
    J Gastrointest Surg; 2005 Jan; 9(1):22-8; discussion 28-9. PubMed ID: 15623441
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
    An YS; Kang DK; Jung YS; Han S; Kim TH
    Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma.
    Liu FY; Chao A; Lai CH; Chou HH; Yen TC
    Gynecol Oncol; 2012 Jun; 125(3):566-71. PubMed ID: 22440787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Monitoring Adhesive Capsulitis After Breast Cancer Treatment.
    Park JH; Lee YK; Kim DH; Kim SJ; Lee JH; Jeon TJ; Ryu YH; Lee JD
    J Comput Assist Tomogr; 2015; 39(3):349-55. PubMed ID: 25700225
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The analysis of factors affecting the threshold on repeated 18F-FDG-PET/CT investigations measured by the PERCIST protocol in patients with esophageal carcinoma.
    Fencl P; Belohlavek O; Harustiak T; Zemanova M
    Nucl Med Commun; 2012 Nov; 33(11):1188-94. PubMed ID: 22828453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.